Zepbound 7.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F21LC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $80,680
Award facts
- Contract value 100% obligated
- $80,680.02 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $80.7K to AmerSourceBergen Drug Corp for the supply of Zepbound (semaglutide) 7.5 mg/0.5 mL pens on January 28, 2026. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and is scheduled for completion by January 29, 2026. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerSourceBergen maintains its corporate headquarters. This delivery order is issued under AmerSourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $1 billion and extending through December 2026, which enables the company to provide a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerSourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as AmerSourceBergen), a major pharmaceutical distributor serving federal agencies including the Department of Veterans Affairs, Defense Health Agency, and U.S. Coast Guard. The parent company holds a separate IDC with DLA Troop Support Medical valued at up to $1 billion through December 2031. AmerSourceBergen's federal contract portfolio demonstrates extensive experience fulfilling medical procurement requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical supplies, positioning the company as a critical vendor in the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F21LC?
SPE2DR26F21LC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26F21LC worth?
The government has obligated $80,680 on SPE2DR26F21LC.
Is contract SPE2DR26F21LC an order under another contract?
Yes. SPE2DR26F21LC is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F21LC competed?
The extent of competition for SPE2DR26F21LC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award